GLP-1 TikTok: Helping or Hurting Patients? | Wegovy, Zepbound, Ozempic & Social Media

<p><strong>Is GLP-1 TikTok helping or hurting patients?</strong></p><p>Millions of people living with obesity turn to TikTok every day for information, support, motivation, and community. But as obesity management medications like <strong>Wegovy®, Zepbound®, Ozempic®,</strong> and <strong>Mounjaro®</strong> become increasingly common, social media has also become one of the most influential sources of obesity treatment information.</p><p>So who is shaping the conversation?</p><p>In this episode of <strong>Weight &amp; Measure</strong>, hosts <strong>Mike Donnelly-Boylen</strong> and <strong>Zach Niemiec</strong> are joined by <strong>Dr. Danna Kashlan</strong> of Johns Hopkins Medicine and <strong>Dr. Lindsey Ogle</strong> for an important discussion inspired by Dr. Kashlan&#39;s research presented at the <strong>2026 American Diabetes Association Scientific Sessions</strong>.</p><p>Her research, <strong>&quot;Who Shapes the GLP-1 Narrative on TikTok?&quot;</strong>, examined highly engaged GLP-1 content and found that <strong>patients, not healthcare professionals, are driving much of the conversation online.</strong></p><p>Together, we explore the growing influence of social media on obesity care and ask an important question:</p><p><strong>Is GLP-1 TikTok helping patients, hurting patients, or both?</strong></p><p>• Why GLP-1 TikTok has become one of the largest online communities for people living with obesity</p><p>• The benefits of peer support, shared lived experience, and patient advocacy</p><p>• The risks of misinformation, comparison culture, unrealistic expectations, and viral health advice</p><p>• How healthcare professionals can better understand the online communities their patients participate in</p><p>• How patients can identify trustworthy obesity medicine information online</p><p>• Why lived experience and evidence based medicine should work together, not compete</p><p>• The future of obesity care in the age of social media</p><p>Whether you&#39;re taking <strong>Wegovy®, Zepbound®, Ozempic®, Mounjaro®</strong>, another obesity management medication, considering treatment, supporting someone living with obesity, creating health content online, or working in obesity medicine, this episode offers an honest and balanced conversation about one of the fastest growing influences on modern obesity care.</p><p><strong>Weight &amp; Measure with Mike and Zach</strong> is a live panel series bringing together leading obesity medicine physicians, researchers, advocates, and people with lived experience for thoughtful conversations that bridge science, clinical care, and the patient experience.</p><p>New episodes premiere live on <strong>On The Pen</strong> before being released on all major podcast platforms.</p><p><strong>Spotify</strong><br><a href="" target="_new" rel="noopener">https://open.spotify.com/show/45vJYXZC0ciTNpfwoc9CVI?si=HicpBPlwQEWD9RhM3t8BjA</a></p><p><strong>Apple Podcasts</strong><br><a href="https://podcasts.apple.com/us/podcast/weight-measure/id1886848263" target="_new" rel="noopener">https://podcasts.apple.com/us/podcast/weight-measure/id1886848263</a></p><p><strong>Amazon Music</strong><br><a href="" target="_new" rel="noopener">https://music.amazon.com/podcasts/183597e3-d4de-4d93-a7c0-55f0cc6018bd/weight-measure?ref=dm_sh_iwSFqgfpShmLX8vRQR2ZxyJ5y</a></p><p>Download the <strong>ProCare Health Non-Surgical Weight Loss &amp; Obesity Management Guide</strong> to support patients using obesity management medications (OMMs):<br><a href="" target="_new" rel="noopener">https://procarenow.com/pages/non-surgical-weight-loss-obesity-management-program</a></p><p></p>